The company has announced its acquisition of a commitment letter for a special loan from financial institutions to facilitate stock repurchase. The total amount of the loan will not exceed RMB 360 million, with a maximum term of 36 months. The repurchase price will be no higher than RMB 48 per share. This decision aims to enhance shareholder value and stabilize the company's stock price.
Summary generated by AI · Always verify with source document
Shenzhen Stable Medical Products Co., Ltd. (hereinafter referred to as "the Company") held its first extraordinary general meeting of shareholders on April 30, 2026, and the 2025 annual general meeting on May 14, 2026. The Company proposed to use the funds raised to implement the stock repurchase plan. The repurchase price shall not exceed RMB 48 per share. The total amount of the repurchase shall not exceed RMB 360 million.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.